And ROC curves indicated that DNAJC10 had a robust and stable prognosis predictive ability for gliomas, by calculating AUC to evaluate, DNAJC10 harbored a high level of AUC value for predicting 1/3/5-year OS in the three glioma cohorts (AUC of 1/3/5-year OS in TCGA: 0.728/0.777/0.690; CGGA-seq1: 0.540/0.585/0.625; CGGA-seq2: 0.642/0.728/0.78; Figure 3D–F). The gene discussed is DNAJC10; the disease is central nervous system cancer.